IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders

Core Points - IGC Pharma, Inc. is a clinical-stage biotechnology company focused on developing innovative treatments for Alzheimer's disease using AI [1] - The company held its Annual Meeting of Stockholders on October 10, 2025, where all proposals disclosed in the Definitive Proxy Statement were approved by the requisite vote [1] - Only stockholders of record as of July 28, 2025, were eligible to vote at the Annual Meeting [1]